Skip to main content
Erschienen in: Abdominal Radiology 1/2004

01.01.2004

Contrast enhanced MR-guided biopsy of hepatocellular carcinoma: a case report

verfasst von: C. W. König, J. Trübenbach, J. Fritz, U. M. Lauer, C. D. Claussen, P. L. Pereira

Erschienen in: Abdominal Radiology | Ausgabe 1/2004

Einloggen, um Zugang zu erhalten

Abstract

Magnetic resonance (MR)–guided liver biopsy was performed in three patients with hepatocellular carcinoma. The tumor was considered (n = 2) or proven (n = 1) inaccessible with ultrasound or computed tomographic guidance. Because all lesions were poorly delineated on nonenhanced MR imaging, contrast agents (Gd-BOPTA, n = 1; ferucarbotran, n = 2) were applied to facilitate biopsy in an open low-field scanner. Postcontrast tumor conspicuity was fair in the patient receiving Gd-BOPTA and excellent in both patients receiving ferucarbotran, and biopsy was successful in all cases.
Literatur
1.
Zurück zum Zitat Frahm, C, Gehl, HB, Weiss, HD, Roßberg, WA 1996Technique of MR-guided core biopsy of abdominal masses using an open low-field scanner: feasibility and first clinical results.Fortschr Rontgenstr1646267 Frahm, C, Gehl, HB, Weiss, HD, Roßberg, WA 1996Technique of MR-guided core biopsy of abdominal masses using an open low-field scanner: feasibility and first clinical results.Fortschr Rontgenstr1646267
2.
Zurück zum Zitat Schmidt, AJ, Kee, ST, Sze, DY, et al. 1999Diagnostic yield of MR-guided liver biopsies compared with CT- and US-guided liver biopsies.J Vasc Interv Radiol1013231329PubMed Schmidt, AJ, Kee, ST, Sze, DY,  et al. 1999Diagnostic yield of MR-guided liver biopsies compared with CT- and US-guided liver biopsies.J Vasc Interv Radiol1013231329PubMed
3.
Zurück zum Zitat Grazioli, L, Morana, G, Caudana, R, et al. 2000Hepatocellular carcinoma.Correlation between gadobenate dimeglumine-enhanced MRI and pathologic findingsInvest Radiol352534CrossRefPubMed Grazioli, L, Morana, G, Caudana, R,  et al. 2000Hepatocellular carcinoma.Correlation between gadobenate dimeglumine-enhanced MRI and pathologic findingsInvest Radiol352534CrossRefPubMed
4.
Zurück zum Zitat Takeshita, K, Nagashima, I, Frui, S, et al. 2002Effect of superparamagnetic iron oxide-enhanced MRI of the liver with hepatocellular carcinoma and hyperplastic nodule.J Comput Assist Tomogr26451455CrossRefPubMed Takeshita, K, Nagashima, I, Frui, S,  et al. 2002Effect of superparamagnetic iron oxide-enhanced MRI of the liver with hepatocellular carcinoma and hyperplastic nodule.J Comput Assist Tomogr26451455CrossRefPubMed
5.
Zurück zum Zitat Tanimoto, A, Yuasa, Y, Shinmoto, H, et al. 2002Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function.Radiology222661666PubMed Tanimoto, A, Yuasa, Y, Shinmoto, H,  et al. 2002Superparamagnetic iron oxide-mediated hepatic signal intensity change in patients with and without cirrhosis: pulse sequence effects and Kupffer cell function.Radiology222661666PubMed
6.
Zurück zum Zitat Lewin, JS, Petersilge, CA, Hatem, SF, et al. 1998Interactive MR imaging-guided biopsy and aspiration with a modified clinical C-arm system.AJR17015931601PubMed Lewin, JS, Petersilge, CA, Hatem, SF,  et al. 1998Interactive MR imaging-guided biopsy and aspiration with a modified clinical C-arm system.AJR17015931601PubMed
7.
Zurück zum Zitat König, CW, Schott, UG, Pereira, PL, et al. 2002MR-guided lumbar sympathicolysis.Eur Radiol1213881393CrossRefPubMed König, CW, Schott, UG, Pereira, PL,  et al. 2002MR-guided lumbar sympathicolysis.Eur Radiol1213881393CrossRefPubMed
8.
Zurück zum Zitat Ward, J, Robinson, PJ 2002How to detect hepatocellular carcinoma in cirrhosis.Eur Radiol1222582272PubMed Ward, J, Robinson, PJ 2002How to detect hepatocellular carcinoma in cirrhosis.Eur Radiol1222582272PubMed
9.
Zurück zum Zitat Semelka, RC, Bagley, AS, Brown, ED, Kroeker, MA 1994Malignant lesions of the liver identified on T1- but not T2-weighted MR images at 1.5 T.J Magn Reson Imaging4315318PubMed Semelka, RC, Bagley, AS, Brown, ED, Kroeker, MA 1994Malignant lesions of the liver identified on T1- but not T2-weighted MR images at 1.5 T.J Magn Reson Imaging4315318PubMed
10.
Zurück zum Zitat Kelekis, NL, Semelka, RC, Worawattanakul, S, et al. 1998Hepatocellular carcinoma in North AmericaAJR17010051013PubMed Kelekis, NL, Semelka, RC, Worawattanakul, S,  et al. 1998Hepatocellular carcinoma in North AmericaAJR17010051013PubMed
11.
Zurück zum Zitat Kirchin, MA, Pirovano, GP, Spinazzi, A 1998Gadobenate dimeglumine (Gd-BOPTA). An overview.Invest Radiol33798809CrossRefPubMed Kirchin, MA, Pirovano, GP, Spinazzi, A 1998Gadobenate dimeglumine (Gd-BOPTA). An overview.Invest Radiol33798809CrossRefPubMed
12.
Zurück zum Zitat Sahani, DV, O’Malley, ME, Bhat, S, et al. 2002Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results.J Comput Assist Tomogr26216222CrossRefPubMed Sahani, DV, O’Malley, ME, Bhat, S,  et al. 2002Contrast-enhanced MRI of the liver with mangafodipir trisodium: imaging technique and results.J Comput Assist Tomogr26216222CrossRefPubMed
13.
Zurück zum Zitat Manfredi, R, Maresca, G, Baron, RL, et al. 1999Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA).J Magn Reson Imaging9704710CrossRefPubMed Manfredi, R, Maresca, G, Baron, RL,  et al. 1999Delayed MR imaging of hepatocellular carcinoma enhanced by gadobenate dimeglumine (Gd-BOPTA).J Magn Reson Imaging9704710CrossRefPubMed
14.
Zurück zum Zitat Reimer, P, Tombach, B 1998Hepatic MRI with SPIO: detection and characterization of focal liver lesions.Eur Radiol811981204CrossRefPubMed Reimer, P, Tombach, B 1998Hepatic MRI with SPIO: detection and characterization of focal liver lesions.Eur Radiol811981204CrossRefPubMed
15.
Zurück zum Zitat Wang, YXJ, Hussain, SM, Krestin, GP 2001Superparamagnetic iron oxide contrast agents: physiochemical characteristics and applications in MR imaging.Eur Radiol1123192331CrossRefPubMed Wang, YXJ, Hussain, SM, Krestin, GP 2001Superparamagnetic iron oxide contrast agents: physiochemical characteristics and applications in MR imaging.Eur Radiol1123192331CrossRefPubMed
16.
Zurück zum Zitat Chen, F, Ward, J, Robinson, PJ 1999MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents.Magn Reson Imaging4549556CrossRef Chen, F, Ward, J, Robinson, PJ 1999MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents.Magn Reson Imaging4549556CrossRef
17.
Zurück zum Zitat Ward, J, Guthrie, JA, Scott, DJ, et al. 2000Hepatocellular carcinoma in the cirrhotic liver: Double-contrast MR imaging for diagnosis.Radiology216154162PubMed Ward, J, Guthrie, JA, Scott, DJ,  et al. 2000Hepatocellular carcinoma in the cirrhotic liver: Double-contrast MR imaging for diagnosis.Radiology216154162PubMed
18.
Zurück zum Zitat Deckers, F, Corthouts, B, Nackaerts, Y, et al. 1997The influence of MR field strength on the detection of focal liver lesions with superparamagnetic iron oxide.Eur Radiol7887892CrossRefPubMed Deckers, F, Corthouts, B, Nackaerts, Y,  et al. 1997The influence of MR field strength on the detection of focal liver lesions with superparamagnetic iron oxide.Eur Radiol7887892CrossRefPubMed
19.
Zurück zum Zitat Rofsky, NM, Yang, BM, Schlossberg, P, et al. 1998MR-guided needle aspiration biopsies of hepatic masses using a closed bore magnet.J Comput Assist Tomogr22633637CrossRefPubMed Rofsky, NM, Yang, BM, Schlossberg, P,  et al. 1998MR-guided needle aspiration biopsies of hepatic masses using a closed bore magnet.J Comput Assist Tomogr22633637CrossRefPubMed
20.
Zurück zum Zitat Duerk, JL, Lewin, JS, Wendt, M, Petersilge, C 1998Remember true FISP? A high SNR, near 1-second imaging method for T2-like contrast in interventional MRI at .2 T.J Magn Reson Imaging8203208PubMed Duerk, JL, Lewin, JS, Wendt, M, Petersilge, C 1998Remember true FISP? A high SNR, near 1-second imaging method for T2-like contrast in interventional MRI at .2 T.J Magn Reson Imaging8203208PubMed
21.
Zurück zum Zitat Chung, YC, Merkle, EM, Lewin, JS, et al. 1999Fast T2-weighted imaging by PSIF at 0.2 T for interventional MRI.Magn Reson Med42335344CrossRefPubMed Chung, YC, Merkle, EM, Lewin, JS,  et al. 1999Fast T2-weighted imaging by PSIF at 0.2 T for interventional MRI.Magn Reson Med42335344CrossRefPubMed
22.
Zurück zum Zitat Constable, RT, Henkelman, RM 1991Contrast, resolution, and detectability in MR imaging.J Comput Assist Tomogr15297303PubMed Constable, RT, Henkelman, RM 1991Contrast, resolution, and detectability in MR imaging.J Comput Assist Tomogr15297303PubMed
23.
Zurück zum Zitat Ward, J, Chen, F, Guthrie, JA, et al. 2000Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis.Radiology214159166PubMed Ward, J, Chen, F, Guthrie, JA,  et al. 2000Hepatic lesion detection after superparamagnetic iron oxide enhancement: comparison of five T2-weighted sequences at 1.0 T by using alternative-free response receiver operating characteristic analysis.Radiology214159166PubMed
Metadaten
Titel
Contrast enhanced MR-guided biopsy of hepatocellular carcinoma: a case report
verfasst von
C. W. König
J. Trübenbach
J. Fritz
U. M. Lauer
C. D. Claussen
P. L. Pereira
Publikationsdatum
01.01.2004
Erschienen in
Abdominal Radiology / Ausgabe 1/2004
Print ISSN: 2366-004X
Elektronische ISSN: 2366-0058
DOI
https://doi.org/10.1007/s00261-003-0060-8

Weitere Artikel der Ausgabe 1/2004

Abdominal Radiology 1/2004 Zur Ausgabe

BookReview

Announcements

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.